[Phase II and III studies of vindesine in children with leukemia and lymphoma].
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D014750:Vincristine / Q000627:therapeutic use; D014751:Vindesine / Q000627:therapeutic use*
D014750:Vincristine; D014751:Vindesine